FreeObituary Tomasi revived basic and clinical research at Roswell Park April 11, 2025Vol.51 No.14By Jerome Yates
FreeIn the Archives Don Thomas’s “secret weapons”—and how a 1970s BMT database continues to lead to new findings April 11, 2025Vol.51 No.14
Conversation with The Cancer Letter Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy April 04, 2025Vol.51 No.13By Paul Goldberg
Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDAMeanwhile, NASEM sounds “SOS” for health infrastructure April 04, 2025Vol.51 No.13By Claire Marie Porter, Paul Goldberg and Jacquelyn Cobb
Conversation with The Cancer Letter Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising recordCurrent record: $507,000. Proceeds to go to LLS as NIH funding is slashed April 04, 2025Vol.51 No.13By Jacquelyn Cobb
Guest Editorial Rathmell: We must put the individual at the center of our approach to ending cancer April 04, 2025Vol.51 No.13By W. Kimryn Rathmell
Sponsored How City of Hope is using AI to improve surgical outcomes April 04, 2025Vol.51 No.13By City of Hope
FreeIn the Archives In an oral history now taken down by FDA, Andrew von Eschenbach recounts his stint as the head of both FDA and NCI—simultaneously April 04, 2025Vol.51 No.13By Jacquelyn Cobb
Conversation with The Cancer Letter Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State March 28, 2025Vol.51 No.12By Paul Goldberg
Capitol Hill Kennedy announces massive cuts, centralization at HHS—NCI and FDA hitAlso this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology March 28, 2025Vol.51 No.12By Claire Marie Porter and Jacquelyn Cobb
